Author:
Isoda Atsushi,Miyazawa Yuri,Ishikawa Tetsuya,Kanaya Shuhei,Nakayama Keita,Mihara Masahiro,Iriuchishima Hirono,Saito Akio,Matsumoto Morio,Sawamura Morio
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Palumbo A, Anderson K (2011) Multiple myeloma. N Engl J Med 364:1046–1060
2. Van Lammeren-Venema D, Regelink JC, Riphagen II, Zweegman S, Hoekstra OS, Zijlstra JM (2012) 18F-fluoro-deoxyglucose positron emission tomography in assessment of myeloma-related bone disease: a systematic review. Cancer 118:1971–1981
3. Cocks K, Cohen D, Wisløff F, Sezer O, Lee S, Hippe E et al (2007) An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma. Eur J Cancer 43:1670–1678
4. Sonmez M, Akagun T, Topbas M, Cobanoglu U, Sonmez B, Yilmaz M et al (2008) Effect of pathologic fractures on survival in multiple myeloma patients : a case control study. J Exp Clin Cancer Res 4:1–4
5. An G, Acharya C, Feng X, Wen K, Zhong M, Zhang L et al (2016) Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implication. Blood 128:1590–1603